Abstract
This article reviews the importance of laboratory testing in the diagnosis of depressive disorders and for management during treatment. There is no useful test to establish the presence of a Major Depressive Episode, but medical conditions requiring laboratory testing should be excluded before arriving at a diagnosis. Treatment may lead to physiologic dysfunction warranting monitoring various laboratory functions. The following tests should be considered in establishing diagnosis and to establish baseline levels for comparison in subsequent monitoring: ■ Electrolytes ■ TSH (and free T4 if TSH is abnormal) ■ CBC with platelet count ■ Creatinine and BUN ■ LFTs (AST, alkaline phosphatase) ■ Calcium and phosphate ■ Pregnancy testing (hCG) for selected female patients. Lithium, carbamazepine, and valproic acid levels should be monitored when these medications are used to treat patients with depression.
Original language | English (US) |
---|---|
Pages (from-to) | 511-514 |
Number of pages | 4 |
Journal | Laboratory Medicine |
Volume | 33 |
Issue number | 7 |
DOIs | |
State | Published - 2002 |
ASJC Scopus subject areas
- Clinical Biochemistry
- Biochemistry, medical